HeimTWST • NASDAQ
add
Twist Bioscience Corp
42,23 $
Eftir lokun(0,54%)-0,23
42,00 $
Lokað: 22. nóv., 17:55:00 GMT-5 · USD · NASDAQ · Lagalegir fyrirvarar
Við síðustu lokun
41,66 $
Dagbil
40,87 $ - 42,96 $
Árabil
23,07 $ - 60,90 $
Markaðsvirði
2,51 ma. USD
Meðalmagn
801,69 þ.
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
NASDAQ
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | sep. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 84,71 m. | 26,53% |
Rekstrarkostnaður | 74,28 m. | 9,52% |
Nettótekjur | -34,66 m. | 25,06% |
Hagnaðarhlutfall | -40,91 | 40,78% |
Hagnaður á hvern hlut | -0,59 | 20,94% |
EBITDA | -31,99 m. | 10,40% |
Virkt skatthlutfall | 0,28% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | sep. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 276,40 m. | -17,84% |
Heildareignir | 614,32 m. | -20,88% |
Heildarskuldir | 141,63 m. | -7,41% |
Eigið fé alls | 472,69 m. | — |
Útistandandi hlutabréf | 59,36 m. | — |
Eiginfjárgengi | 5,19 | — |
Arðsemi eigna | -14,39% | — |
Ávöxtun eigin fjár | -15,86% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | sep. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | -34,66 m. | 25,06% |
Handbært fé frá rekstri | -15,32 m. | 26,00% |
Reiðufé frá fjárfestingum | -1,28 m. | 42,81% |
Reiðufé frá fjármögnun | 3,63 m. | 720,59% |
Breyting á handbæru fé | -12,90 m. | 42,79% |
Frjálst peningaflæði | -6,51 m. | 34,40% |
Um
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
Framkvæmdastjóri
Stofnsett
2013
Vefsvæði
Starfsfólk
923
